Medical research

Tunable bonds: A step towards targeted At-211 cancer therapy

Astatine is the least abundant element on Earth, and all of its known isotopes have a half-life of less than 8 hours. One astatine isotope, astatine-211 (At-211), emits alpha particles and shows promise as a cancer therapy. ...

Ophthalmology

New research may revolutionise cataract treatment

World-leading eye experts have made a breakthrough that could potentially change the way cataracts are treated—with potential for drug therapy to replace surgery.

Oncology & Cancer

The promise of particle beam cancer therapy

Accelerator physicists are natural-born problem solvers, finding ever more powerful ways to generate and steer particle beams for research into the mysteries of physics, materials, and matter. And from the very beginning, ...

page 2 from 3